Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
Authors
Keywords
Non-small cell lung cancer, Lung and intrathoracic tumors, Biomarkers, Cancer detection and diagnosis, Diagnostic medicine, Small cell lung cancer, Histology, Secondary lung tumors
Journal
PLoS One
Volume 10, Issue 5, Pages e0127318
Publisher
Public Library of Science (PLoS)
Online
2015-05-19
DOI
10.1371/journal.pone.0127318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
- (2014) Ji-Won Kim et al. Cancer Research and Treatment
- Characteristics of Lung Cancers Detected by Computer Tomography Screening in the Randomized NELSON Trial
- (2013) Nanda Horeweg et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- American Cancer Society lung cancer screening guidelines
- (2013) Richard Wender et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epidemiology of Lung Cancer
- (2013) Anthony J. Alberg et al. CHEST
- Soluble CD26 Levels and Its Association to Epidemiologic Parameters in a Sample Population
- (2013) Loretta De Chiara et al. DISEASE MARKERS
- Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
- (2013) Mazyar Javidroozi et al. DISEASE MARKERS
- European randomized lung cancer screening trials: Post NLST
- (2013) John K. Field et al. JOURNAL OF SURGICAL ONCOLOGY
- Prospects for population screening and diagnosis of lung cancer
- (2013) John K Field et al. LANCET
- Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice
- (2013) James R. Jett et al. LUNG CANCER
- Worldwide Overview of the Current Status of Lung Cancer Diagnosis and Treatment
- (2012) Paul A. Bunn ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Calprotectin: a novel biomarker for the diagnosis of pleural effusion
- (2012) N Sánchez-Otero et al. BRITISH JOURNAL OF CANCER
- A Multiplexed Serum Biomarker Immunoassay Panel Discriminates Clinical Lung Cancer Patients from High-Risk Individuals Found to be Cancer-Free by CT Screening
- (2012) William L. Bigbee et al. Journal of Thoracic Oncology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel detection method of non–small cell lung cancer using multiplexed bead-based serum biomarker profiling
- (2011) Hyun Joo Lee et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas
- (2010) Loretta De Chiara et al. BMC CANCER
- A multi-analyte serum test for the detection of non-small cell lung cancer
- (2010) E C Farlow et al. BRITISH JOURNAL OF CANCER
- Impact of Serum Hepatocyte Growth Factor on Treatment Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Adenocarcinoma
- (2010) K. Kasahara et al. CLINICAL CANCER RESEARCH
- Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer: A Systematic Review with Meta-Analysis
- (2010) Ping Zhan et al. Journal of Thoracic Oncology
- Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey
- (2010) Daniel Morgensztern et al. Journal of Thoracic Oncology
- On the origin of serum CD26 and its altered concentration in cancer patients
- (2009) Oscar J. Cordero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis
- (2009) Saeid Ghavami et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Multiparametric Serum Kallikrein Panel for Diagnosis of Non-Small Cell Lung Carcinoma
- (2008) C. Planque et al. CLINICAL CANCER RESEARCH
- Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells
- (2008) Marianela Perez-Torres et al. EXPERIMENTAL CELL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search